Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana Luisa Rivera-Lazarín"'
Autor:
Ana Luisa Rivera-Lazarín, Kenny Misael Calvillo-Rodríguez, Mizael Izaguirre-Rodríguez, José Manuel Vázquez-Guillén, Ana Carolina Martínez-Torres, Cristina Rodríguez-Padilla
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 14, p 7938 (2024)
T-cell malignancies, including T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), present significant challenges to treatment due to their aggressive nature and chemoresistance. Chemotherapies remain a mainstay for
Externí odkaz:
https://doaj.org/article/914dc5063b80432b8019c4cf4d951c8e
Autor:
Ana Luisa Rivera-Lazarín, Ana Carolina Martinez-Torres, Rafael de la Hoz-Camacho, Olga Liliana Guzmán-Aguillón, Moisés Armides Franco-Molina, Cristina Rodríguez-Padilla
Publikováno v:
EXCLI Journal : Experimental and Clinical Sciences, Vol 22, Pp 131-145 (2023)
Breast cancer (BC) is one of the leading causes of cancer death worldwide. Cyclophosphamide (CTX) remains a mainstay in cancer therapy despite harmful adverse effects and cell death-resistances. To face this, combinational therapy of chemotherapies a
Externí odkaz:
https://doaj.org/article/a25cfd10aee144dc9c92ff3c1713c56c
Autor:
Rafael de la Hoz-Camacho, Ana Luisa Rivera-Lazarin, Jose Manuel Vazquez-Guillen, Diana Caballero-Hernandez, Edgar Mendoza-Gamboa, Ana Carolina Martinez-Torres, Cristina Rodriguez-Padilla
Publikováno v:
EXCLI Journal : Experimental and Clinical Sciences, Vol 21, Pp 197-212 (2022)
Chemotherapy Related Cognitive Impairment (CRCI), also called chemobrain, diminishes cancer patient’s life quality. Breast cancer (BC) patients have been described to be importantly affected, however, the mechanism leading to CRCI has not been full
Externí odkaz:
https://doaj.org/article/ad9fb72bf61c4120a3b5ede5ff362ef6